twitter Tweet

Nature names OHSU among top 20 research institutions

Ranking measures impact and contributions to innovation
Promising microRNA study
OHSU was named among the top 20 research institutions worldwide, based on academic research that impacts innovation. (OHSU/Kristyna Wentz-Graff)

OHSU was named among the top 20 research institutions in the world in the journal Nature’s Index 2017 Innovation supplement, which evaluated academic research institutions’ impact on innovation.

To rank the impact of institutions worldwide, the journal examined how research articles are cited in third-party patents. By looking at patents owned by third parties, rather than those held by institutions themselves, the influence of research on the development of products and services is evident, according to the journal.

OHSU stood out in two ways:

  • It placed in the top 20 based on an analysis using Nature’s “normalized lens influence metric.” This metric takes 200 high performing institutions that appear in the top 100 of at least one of a selection of institutional rankings. It then measures citations of research articles in patents owned by third parties, producing the score.
  • More than 13 percent of all OHSU’s natural science articles appear in the Nature Index.  This index provides a measure of an institutions’ output relative to its overall research capacity.
Daniel Dorsa, Ph.D.
Daniel Dorsa, Ph.D.

“Our ranking reflects the high caliber of our faculty — not only are they publishing in excellent journals, but their discoveries are having real-world impact in patents for products that advance knowledge and improve human health,” said Daniel Dorsa, Ph.D., OHSU's senior vice president for research. 

Nature’s description of its analysis, which includes the institution’s research articles, collaborations and relationships, was published as a supplement to Nature. For more information about the index, see Nature’s FAQ.

Previous Story OHSU encourages all Oregonians to renew or sign up for health insurance Next Story Clinical trial results show promise for drug targeting rare stomach cancer
Facebook Twitter LinkedIn YouTube Instagram OHSU Braille services OHSU sign language services OHSU interpreter services X